Hindustan Agrigenetics Limited has filed its mandatory yearly disclosure under SEBI's Substantial Acquisition of Shares & Takeovers (SAST) Regulations with BSE Limited for the financial year ended March 31, 2026. The disclosure, submitted on April 07, 2026, confirms compliance with regulatory requirements for promoter shareholding transparency.

Regulatory Compliance Details

The disclosure was filed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The document was submitted to BSE Limited's Department of Corporate Services for the company's scrip code 519574.

Promoter Declaration

Rajendra Naniwadekar, Managing Director and Promoter of hindustan agrigenetics , provided a formal declaration regarding promoter shareholding activities during FY26. The declaration specifically addressed encumbrance activities by promoter and promoter group members.

Key Disclosure Statement

The promoter declaration confirmed that no encumbrance was made, directly or indirectly, over the company's shares during the financial year ended March 31, 2026. This declaration covers both the promoter and all promoter group members, ensuring complete transparency in shareholding activities.

Corporate Information

The disclosure was signed digitally by Rajendra Naniwadekar, who serves as Managing Director with DIN 00032107. The company maintains its registered office at C-1/5, Second Floor, Safdarjung Development Area, Hauz Khas, New Delhi-110016, with correspondence address at C 63, South Extension Part-II, New Delhi 110 049. The filing represents the company's ongoing commitment to regulatory compliance and corporate governance standards under SEBI guidelines.

Hindustan Agrigenetics Limited has issued a clarification to BSE Limited regarding a typographical error in its earlier CFO appointment intimation dated March 14, 2026. The company confirmed that the correct name of the newly appointed Chief Financial Officer is Mr. Suresh Srinivasan, not "Sursh Srinivasan" as previously mentioned due to an inadvertent error.

Clarification and Correction Details

The clarification was submitted on March 16, 2026, addressing the typographical mistake in the original appointment intimation. The company emphasized that all other details provided in the earlier communication remain unchanged, including the appointment effective date and terms of engagement.

Regulatory Compliance and Documentation

The original Board of Directors meeting was held on March 14, 2026, from 03:00 PM to 04:00 PM, where the CFO appointment was formally approved. The appointment was made pursuant to Section 203 of the Companies Act, 2013 and applicable provisions of SEBI (LODR) Regulations, 2015, based on recommendations from both the Nomination and Remuneration Committee and Audit Committee.

Professional Background and Company Structure

Mr. Suresh Srinivasan brings extensive professional experience in finance and accounting, taxation matters, corporate compliance, and financial management to his new role. The appointment strengthens the company's financial leadership structure as it continues operations in the agrigenetics sector.

The clarification was signed by Managing Director Rajendra Naniwadekar (DIN- 00032107) and submitted to BSE Limited as part of the company's ongoing regulatory compliance requirements. The company's registered office is located at C-1/5, Second Floor, Safdarjung Development Area, Hauz Khas, New Delhi-110016.